Merck&Co earnings, Revenue beat in Q3

  • Investing.com
  • Stock Market News
Merck&Co earnings, Revenue beat in Q3
Credit: © Reuters.

Investing.com - Merck (NS: PROR )&Co reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Merck&Co announced earnings per share of $1.75 on revenue of $13.15B. Analysts polled by Investing.com anticipated EPS of $1.54 on revenue of $12.26B.

Merck&Co shares are up 7% from the beginning of the year and are trading at $81.54 , down-from-52-week-high.They are under-performing the Dow Jones which is up 15.96% year to date.

Merck&Co follows other major Healthcare sector earnings this month

Merck&Co's report follows an earnings beat by Hoya Corp on Thursday, who reported EPS of $1.02 on revenue of $1.43B, compared to forecasts EPS of $0.9772 on revenue of $1.42B.

Iqvia had beat expectations on Thursday, October 21, 2021 with third quarter EPS of $2.17 on revenue of $3.39B, compared to forecast for EPS of $2.12 on revenue of $3.35B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles